You are here: Industry Insights > GMP

News List

Evolving World of Pharma: Staying up to date with GMP Sarah Harding
February 11, 2019
Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards.
To Accelerate Linking up with the International Standards, China Making Efforts to Join PIC/S, Another World-class Organization PharmaSources/Dishui Sinan
January 30, 2019
The “Work Plan for 2019” of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) was fresh out on Jan. 1, 2019, and the news “China will Join PIC/S, Another World-class Organization...
Five more countries to join EMA-FDA mutual recognition europeanpharmaceuticalreview
December 07, 2018
The US FDA has announced that it will confirm the capability of five more countries to carry out good manufacturing practice (GMP)…
Chinese heparin maker banned by EMA over contamination risks fiercepharma
December 04, 2018
World regulators are cautious about crude heparin after China-made APIs were responsible for dozens of deaths in the U.S. more than a decade ago.
Digital manufacturing is a top priority for life sciences cphi-online
December 03, 2018
The company conducted a survey of business and operational leaders across the life science sector on the trends and technologies that may revolutionise the industry over the coming years.
PARI Devices Used in SHIP Study of Hypertonic Saline in Preschoolers with Cystic Fibrosis americanpharmaceuticalreview
November 30, 2018
A recent study in preschoolers with cystic fibrosis (CF) conducted by Cystic Fibrosis Foundation Therapeutics used PARI's LC Sprint Jr. nebulizer, Vios PRO compressor.....
Paragon Named to Deloitte's Technology Fast 500 contractpharma
November 27, 2018
Paragon Bioservices was named to Deloitte's Technology Fast 500™ for 2018, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies
ASIT Biotech Adds GMP Manufacturing Unit contractpharma
November 27, 2018
ASIT biotech has installed and qualified a clean room with the equipment to produce, in compliance with GMP requirements, the API for the Phase I/II studies in house dust mite and peanut allergies treatment.
CASI To Build GMP Mfg. Site In Wuxi, China contractpharma
November 19, 2018
CASI Pharmaceuticals has entered into agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Econ
CASI To Build GMP Mfg. Site In Wuxi, China contractpharma
November 19, 2018
CASI Pharmaceuticals has entered into agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Economic Development Zone in Jiangsu Province, China. The Wuxi Huishan Economic Development Zone is a science and technology innovation cen

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page